SEC Form 4 · accession 0001781127-26-000010
CareDx, Inc. · CDNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Walter Hanna Jr.
Officer — President and CEO · Director
Period of report
Jun 4, 2026
Accepted (ET)
Jun 30, 2026 · 5:29 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001217234
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 4, 2026 | M | 706 | $8.20 | A | 632,665 | D | |
| Common Stock | Jun 11, 2026 | M | 13,618 | $8.20 | A | 646,283 | D | |
| Common Stock | Jun 15, 2026 | M | 15,676 | $8.20 | A | 661,959 | D | |
| Common Stock | Jun 26, 2026 | M | 100 | $8.20 | A | 662,059 | D | |
| Common Stock | Jun 26, 2026 | S | 100 | $29.00 | D | 661,959 | D | |
| Common Stock | Jun 29, 2026 | M | 39,900 | $8.20 | A | 701,859 | D | |
| Common StockF2 | Jun 29, 2026 | S | 39,900 | $29.244 | D | 661,959 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $8.20 | Jun 4, 2026 | M | 706 | D | — | Apr 14, 2034 | Common Stock | 706 | 700,000 | D |
| Employee Stock Option (right to buy)F3 | $8.20 | Jun 11, 2026 | M | 13,618 | D | — | Apr 14, 2034 | Common Stock | 13,618 | 686,382 | D |
| Employee Stock Option (right to buy)F3 | $8.20 | Jun 15, 2026 | M | 15,676 | D | — | Apr 14, 2034 | Common Stock | 15,676 | 670,706 | D |
| Employee Stock Option (right to buy)F3 | $8.20 | Jun 26, 2026 | M | 100 | D | — | Apr 14, 2034 | Common Stock | 100 | 670,606 | D |
| Employee Stock Option (right to buy)F3 | $8.20 | Jun 29, 2026 | M | 39,900 | D | — | Apr 14, 2034 | Common Stock | 39,900 | 630,706 | D |
Explanation of responses
- F1The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
- F2The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.58 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F31/4th of the shares subject to the option shall vest on April 15, 2025 and 1/48th of the shares subject to the option shall vest monthly thereafter.